Dr. Shelly Rishty, MD

Dr. Rishty practices at Robert Wood Johnson University Hospital in New Brunswick, New Jersey, part of RWJBarnabas Health.

Dr. Rishty's NPI, 1053678672, was assigned on April 19, 2012. Dr. Rishty graduated from State University of New York Downstate Medical Center in 2012. Dr. Rishty holds New Jersey license 25MA10149200.

Dr. Rishty's primary practice is Robert Wood Johnson University Hospital, at One Robert Wood Johnson Place, New Brunswick, NJ 08901 in Middlesex County. The practice phone is (732) 828-3000. Dr. Rishty also practices at Robert Wood Johnson University Hospital - New Brunswick, 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901.

Dr. Rishty's primary practice is Robert Wood Johnson University Hospital in New Brunswick, New Jersey, part of RWJBarnabas Health. Dr. Rishty is also affiliated with Robert Wood Johnson University Hospital Hamilton. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Rishty to 2 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rishty practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Rishty's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Rishty's licenses on file in 2 states: New Jersey and New York.

CMS data shows 424 Medicare services from Dr. Rishty across 9 procedure codes in 2024, for 270 Medicare patients. Medicare paid $50,271 for them.

CMS counts 270 Medicare patients who saw Dr. Rishty in 2024. The largest group is 65 to 74, with 86 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rishty's median patient age at 65, with 53% women.

In 2024, Dr. Rishty wrote 807 Medicare Part D claims for 142 patients. 80% of them were for generic drugs. CMS names the drug for 581 of them, across 19 drugs with 11 or more claims each, at $196,908 in total drug cost. In 2023, CMS named 442 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Rishty for performance year 2024, reported as part of a group. Dr. Rishty accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rishty as offering telehealth.

Dmand AI links 3 papers to Dr. Rishty, published from 2020 to 2024. Dr. Rishty has published most often in Epilepsy Behav. Dr. Rishty's most frequent co-authors are Lisa M. Bateman, MD, Brad K. Kamitaki, MD and Lawrence Charles Kleinman, MD.

CMS Open Payments shows 6 general payments to Dr. Rishty from 5 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. UCB, Inc. paid the most, $124.

Dr. Rishty graduated from State University of New York Downstate Medical Center in 2012.